Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.55
+0.30 (4.80%)
Oct 19, 2026, 4:00 PM EDT - Market closed
Inogen Revenue
Inogen had revenue of $95.08M in the quarter ending June 30, 2026, with 3.04% growth. This brings the company's total for the last twelve months to $354.30M, up 3.15% year-over-year. In the year 2025, Inogen had annual revenue of $348.67M with 3.86% growth. That makes Inogen the 13,338th largest company in the world by revenue and 2,505th in the United States.
Revenue (ttm)
$354.30M
Revenue Growth
+3.15%
P/S Ratio
0.49
Revenue / Employee
$470,523
Employees
753
Market Cap
173.83M
Revenue by Geography
- United States 209.84M 60.2%
- Europe 118.00M 33.8%
- Other International 20.82M 6.0%
Fiscal year ended Dec 31, 2025 See the full Inogen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 348.67M | 12.96M | 3.86% |
| Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
| Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
| Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
| Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
| Dec 31, 2020 | 308.49M | -53.46M | -14.77% |
| Dec 31, 2019 | 361.94M | 3.83M | 1.07% |
| Dec 31, 2018 | 358.11M | 108.67M | 43.57% |
| Dec 31, 2017 | 249.44M | 46.61M | 22.98% |
| Dec 31, 2016 | 202.83M | 43.82M | 27.56% |
| Dec 31, 2015 | 159.01M | 46.47M | 41.29% |
| Dec 31, 2014 | 112.54M | 37.09M | 49.17% |
| Dec 31, 2013 | 75.44M | 26.87M | 55.31% |
| Dec 31, 2012 | 48.58M | 17.94M | 58.57% |
| Dec 31, 2011 | 30.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Neuronetics | 155.10M |
| Quanterix | 153.41M |
| RxSight | 127.58M |
| Owlet | 114.41M |
| Standard BioTools | 84.60M |
| Electromed | 73.78M |
| TriSalus Life Sciences | 45.08M |
| MaxCyte | 31.05M |
INGN News
- 4 days ago - Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026 - Business Wire
- 19 days ago - Inogen to divest U.S. oxygen rental business to Rotech Healthcare - TheFly
- 19 days ago - Inogen board approves increase of $15M to existing share buyback authorization - TheFly
- 19 days ago - Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech - Business Wire
- 2 months ago - Inogen Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Inogen Earnings release: Q2 2026 - Filings
- 2 months ago - Inogen Slides: Q2 2026 - Filings
- 2 months ago - Inogen Quarterly report: Q2 2026 - Filings